Accueil
Envoyer à un ami
Imprimer
Grand
Petit
Partager
ACTUALITES

Takeda Reports First Half FY2016 Results and Raises Full Year Profit Guidance


- 28 Octobre 2016 modifié le 1 Janvier 1970


(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TOKYO:4502):

Strong first half results led by Growth Drivers

  • Underlying Revenue grew +7.4%, led by a +15.3% increase of Takeda's Growth Drivers
    (GI, Oncology, CNS and Emerging Markets). Reported revenue declined -5.9%, due to unfavorable currencies (-8.6pt) and the impact of divestitures (-4.7pt).
  • Underlying Core Earnings advanced +12.7% with the Core Earnings margin increasing by 0.7pt. Despite unfavorable currencies and the negative impact of divestitures, reported operating profit was up +46.7% benefiting from strong underlying growth and a one-time gain on the Teva JV transaction.
  • Underlying Core EPS was up +49.3%, reflecting strong Core Earnings growth and a lower tax rate due to timing. Reported EPS more than doubled to 159 yen, up from 69 yen in the prior year period.
  • Reported Operating Free Cash Flow was up 34.0% to 74. ...

    Source : http://me-newswire.net//news/18946/en...


ACTUALITES | INTERNATIONAL | TCHAD | POLITIQUE | CULTURE | EXCLUSIF | Revue de Presse | English News | 中國